How to buy BARD1 Life Sciences (BD1) shares
Learn how to easily invest in BARD1 Life Sciences shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
BARD1 Life Sciences Limited is a diagnostics & research business based in Australia. BARD1 Life Sciences shares (BD1) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. BARD1 Life Sciences has a trailing 12-month revenue of around $468,096. If you're looking to buy shares, check out the steps below.
How to buy shares in BARD1 Life Sciences
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for BARD1 Life Sciences. Find the share by name or ticker symbol: BD1. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until BARD1 Life Sciences reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of BARD1 Life Sciences. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- BARD1 Life Sciences key stats
- Compare share trading platforms
- Is BARD1 Life Sciences stock a buy or sell?
- BARD1 Life Sciences performance over time
- BARD1 Life Sciences's financials
- How volatile are BARD1 Life Sciences shares?
- Does BARD1 Life Sciences pay a dividend?
- Have BARD1 Life Sciences shares ever split?
- Other common questions
BARD1 Life Sciences stock price (ASX:BD1)Use our graph to track the performance of BD1 stocks over time.
BARD1 Life Sciences shares at a glance
|52-week range||$0.57 - $5.6|
|50-day moving average||$1.39|
|200-day moving average||$2.2679|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.16|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy BARD1 Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
BARD1 Life Sciences price performance over time
|1 week (2021-09-16)||-14.18%|
|1 month (2021-08-26)||-22.82%|
|3 months (2021-06-25)||-41.92%|
|6 months (2021-03-26)||-69.50%|
|1 year (2020-09-25)||-94.89%|
|2 years (2019-09-26)||-96.55%|
|3 years (2018-09-26)||-88.03%|
|5 years (2016-09-26)||-95.61%|
BARD1 Life Sciences financials
|Gross profit TTM||$291,974|
|Return on assets TTM||-20.52%|
|Return on equity TTM||-72.08%|
|Market capitalisation||$105.7 million|
TTM: trailing 12 months
BARD1 Life Sciences share dividends
We're not expecting BARD1 Life Sciences to pay a dividend over the next 12 months.
Have BARD1 Life Sciences's shares ever split?
BARD1 Life Sciences's shares were split on a 1:30 basis on 30 November 2020. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BARD1 Life Sciences shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for BARD1 Life Sciences shares which in turn could have impacted BARD1 Life Sciences's share price.
BARD1 Life Sciences share price volatility
Over the last 12 months, BARD1 Life Sciences's shares have ranged in value from as little as $0.57 up to $5.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while BARD1 Life Sciences's is -0.764. This would suggest that BARD1 Life Sciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, BARD1 Life Sciences has bucked the trend.
BARD1 Life Sciences overview
BARD1 Life Sciences Limited engages in the research, development, and commercialization of non-invasive diagnostic products for the early detection of cancer to enhance patient outcomes and save lives in Australia. Its cancer diagnostics portfolio includes commercialized hTERT test used as an adjunct to urine cytology testing; and diagnostic tests in development for ovarian, breast, lung, prostate, and pancreatic cancers. The company is also providing Molecular NET technology, including its EXO-NETTM product to capture and purify exosomes. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in Notting Hill, Australia.
Stocks similar to BARD1 Life Sciences
BARD1 Life Sciences in the news
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert